Acura Pharmaceuticals Inc (ACUR)
0.003
-0.01
(-70.00%)
USD |
OTCM |
May 02, 12:40
Acura Pharmaceuticals Max Drawdown (5Y): 99.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.99% |
March 31, 2024 | 99.99% |
February 29, 2024 | 99.99% |
January 31, 2024 | 99.99% |
December 31, 2023 | 99.99% |
November 30, 2023 | 99.97% |
October 31, 2023 | 99.97% |
September 30, 2023 | 99.97% |
August 31, 2023 | 99.97% |
July 31, 2023 | 99.97% |
June 30, 2023 | 99.97% |
May 31, 2023 | 99.97% |
April 30, 2023 | 99.97% |
March 31, 2023 | 99.97% |
February 28, 2023 | 99.97% |
January 31, 2023 | 99.97% |
December 31, 2022 | 99.86% |
November 30, 2022 | 99.86% |
October 31, 2022 | 99.86% |
September 30, 2022 | 99.86% |
August 31, 2022 | 99.86% |
July 31, 2022 | 99.86% |
June 30, 2022 | 99.26% |
May 31, 2022 | 99.26% |
April 30, 2022 | 99.26% |
Date | Value |
---|---|
March 31, 2022 | 99.26% |
February 28, 2022 | 99.26% |
January 31, 2022 | 99.26% |
December 31, 2021 | 99.26% |
November 30, 2021 | 99.26% |
October 31, 2021 | 99.26% |
September 30, 2021 | 99.26% |
August 31, 2021 | 99.26% |
July 31, 2021 | 99.26% |
June 30, 2021 | 99.26% |
May 31, 2021 | 99.26% |
April 30, 2021 | 99.26% |
March 31, 2021 | 99.26% |
February 28, 2021 | 99.26% |
January 31, 2021 | 99.26% |
December 31, 2020 | 99.26% |
November 30, 2020 | 99.26% |
October 31, 2020 | 99.26% |
September 30, 2020 | 99.26% |
August 31, 2020 | 99.26% |
July 31, 2020 | 99.26% |
June 30, 2020 | 99.26% |
May 31, 2020 | 99.26% |
April 30, 2020 | 99.26% |
March 31, 2020 | 99.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.26%
Minimum
May 2019
99.99%
Maximum
Dec 2023
99.51%
Average
99.26%
Median
May 2019
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |